Showing results (131-140 of 160) with videos related to
Sort By:
Pageof 16
Journal of General Internal Medicine|June 28, 2007
Does affiliation of physician groups with one another produce higher quality primary care?Mark W Friedberg, Kathryn L Coltin, Steven D Pearson, et al.Journal of Managed Care & Specialty Pharmacy|January 27, 2023
The effectiveness and value of AMX0035 and oral edaravone for amyotrophic lateral sclerosis: A summary from the Institute for Clinical and Economic Review's Midwest Comparative Effectiveness Public Advisory CouncilDmitriy Nikitin, Anil N Makam, Kangho Suh, et al.Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|December 8, 2016
Assessing the value of mepolizumab for severe eosinophilic asthma: a cost-effectiveness analysisMelanie D Whittington, R Brett McQueen, Daniel A Ollendorf, et al.Journal of Managed Care & Specialty Pharmacy|July 5, 2023
Oral and monoclonal antibody treatments for relapsing forms of multiple sclerosis: Effectiveness and valueAvery McKenna, Grace A Lin, Melanie D Whittington, et al.Journal of Managed Care & Specialty Pharmacy|April 30, 2020
The Effectiveness and Value of Oral Immunotherapy and Viaskin Peanut for Peanut AllergyJeffrey A Tice, Gregory F Guzauskas, Ryan N Hansen, et al.Annals of Internal Medicine|June 20, 2013
Observation versus initial treatment for men with localized, low-risk prostate cancer: a cost-effectiveness analysisJulia H Hayes, Daniel A Ollendorf, Steven D Pearson, et al.Journal of Managed Care & Specialty Pharmacy|April 26, 2022
The effectiveness and value of tezepelumab for severe asthmaDavid M Rind, R Brett McQueen, Serina Herron-Smith, et al.Health Affairs (Project Hope)|May 14, 2008
Crossroads in qualityMargaret O'Kane, Janet Corrigan, Sandra M Foote, et al.Journal of Managed Care & Specialty Pharmacy|November 28, 2018
Cost-Effectiveness of Targeted Pharmacotherapy for Moderate to Severe Plaque PsoriasisNathaniel Hendrix, Daniel A Ollendorf, Richard H Chapman, et al.Journal of Managed Care & Specialty Pharmacy|December 24, 2021
JAK inhibitors and monoclonal antibodies for the treatment of atopic dermatitis: effectiveness and valueFoluso Agboola, Steven J Atlas, Elizabeth Brouwer, et al.Pageof 16